Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

NCT01931566 ·Status: TERMINATED ·Phase: PHASE3

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

NCT00293176 ·Status: COMPLETED ·Phase: PHASE4

Senicapoc in Alzheimer's Disease

NCT04804241 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease

NCT02221947 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

NMDA Enhancement Combined With Omega-3 for Early Dementia

NCT05181189 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients

NCT05050604 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment

NCT02982642 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

NCT02615002 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

NCT00483028 ·Status: COMPLETED ·Phase: NA

Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC

NCT01366820 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment

NCT00736034 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment

NCT00437983 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of MEMORMAX in Subjects With MCI

NCT03581929 ·Status: COMPLETED ·Phase: NA

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

NCT01072812 ·Status: TERMINATED ·Phase: PHASE1

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187 ·Status: TERMINATED ·Phase: PHASE3

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

NCT00566397 ·Status: COMPLETED ·Phase: PHASE2

Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment

NCT04078178 ·Status: COMPLETED ·Phase: NA

The Memory and Cognitive Performance Study

NCT04025255 ·Status: COMPLETED ·Phase: NA

Study of NNZ-2566 in Patients With Traumatic Brain Injury

NCT00805818 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

NCT03625622 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

NCT04795466 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01028911 ·Status: TERMINATED ·Phase: PHASE1

A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

NCT04669028 ·Status: COMPLETED ·Phase: PHASE3